Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Eton Pharmaceuticals
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
July 29, 2026
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
May 30, 2026
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
May 29, 2026
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
May 28, 2026
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
May 27, 2026
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
May 26, 2026
Eton Pharmaceuticals Announces CFO Succession Plan
May 25, 2026
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
May 22, 2026
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
May 21, 2026
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
May 16, 2026
1
2
Next Page
→